Upregulated NOTCH2 Expression Is Implicated in the Clinical Aggressiveness of Atypical Fibroxanthoma and Pleomorphic Dermal Sarcoma
International Journal of Dermatology · 2025
DOI: 10.1111/ijd.17844 ↗At a glance
Journal article in International Journal of Dermatology, 2025. Written by Yi-Pei Lee and 4 co-authors. Institution: Department of Dermatology, Venerology and Allergology, St. Josef Hospital, Ruhr-University Bochum, Bochum, Germany. Major MEDLINE topics: Receptor, Notch2, Skin Neoplasms, Neoplasm Recurrence, Local, Sarcoma. 31 references. The full text is freely available (open access, CC BY 4.0).
Abstract (original language)
Background
Atypical fibroxanthoma (AFX) and pleomorphic dermal sarcoma (PDS) represent clinicopathological variants of a spectrum. It is known that AFX and PDS tumors harbor frequent NOTCH1/2 mutations. However, the expression of Notch signaling pathway‐associated proteins in both tumor cells has not been studied before.
Methods
We conducted an immunohistochemical study by performing NOTCH1, NOTCH2, NICD, and HES1 staining on the most representative formalin‐fixed paraffin‐embedded (FFPE) tumor tissues out of sixty‐two patients with the first diagnosis of either AFX ( n = 33) or PDS ( n = 29) in a single tertiary medical center.
Results
Ten patients (PDS, n = 9; AFX, n = 1) had disease progression in terms of locoregional relapse, including local recurrence and regional lymph node metastasis, with a median time‐to‐(first)‐recurrence interval of 8 months after a wide local excision. Among all the Notch expression profiles, only the upregulated NOTCH2 expression has a positive correlation with disease progression [odds ratio (OR): 1.02, 95% confidence interval (CI): 1–1.04, p = 0.029]. Furthermore, HES1 is activated through the NOTCH2 signaling pathway ( r (60) = 0.27, p = 0.032) rather than NOTCH1, and NOTCH1 does not appear to be functionally active.
Conclusions
Upregulated NOTCH2 expression plays a significant role in disease progression, in part through the canonical signaling pathway involving the downstream effector HES1. Targeting NOTCH2 signaling might hold therapeutic promise in patients with disease progression.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Dermatology, Venerology and Allergology, St. Josef Hospital, Ruhr-University Bochum, Bochum, Germany.
- Department of Dermatology, Dortmund Hospital gGmbH, University Witten/Herdecke, Germany.
ORCID profiles: Yi-Pei Lee
Cite
APA
Lee, Y. P., Razegphpour, F., Sorescu, E., Stücker, M., & Gambichler, T. (2025). Upregulated NOTCH2 Expression Is Implicated in the Clinical Aggressiveness of Atypical Fibroxanthoma and Pleomorphic Dermal Sarcoma. International Journal of Dermatology. https://doi.org/10.1111/ijd.17844
Vancouver
Lee YP, Razegphpour F, Sorescu E, Stücker M, Gambichler T. Upregulated NOTCH2 Expression Is Implicated in the Clinical Aggressiveness of Atypical Fibroxanthoma and Pleomorphic Dermal Sarcoma. International Journal of Dermatology. 2025. doi:10.1111/ijd.17844
BibTeX
@article{Lee2025,
author = {Lee, Yi-Pei and Razegphpour, Fahimeh and Sorescu, Emilia and Stücker, Markus and Gambichler, Thilo},
title = {Upregulated NOTCH2 Expression Is Implicated in the Clinical Aggressiveness of Atypical Fibroxanthoma and Pleomorphic Dermal Sarcoma},
journal = {International Journal of Dermatology},
year = {2025},
doi = {10.1111/ijd.17844}
}
EUVIMED